APO Research
Talk to an analyst

APO RESEARCH · REPORT

Commercial Drug Procurement

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Commercial Drug Procurement Market Analysis and Forecast 2026-2032

3 March 2026193 pages

Choose your research edition.

Industry ResearchCommercial Drug Procurement Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Commercial Drug Procurement Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Commercial Drug Procurement Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Commercial Drug Procurement Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Commercial Drug Procurement Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Commercial Drug Procurement market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Commercial Drug Procurement is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Commercial Drug Procurement is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Commercial Drug Procurement is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Commercial Drug Procurement is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Commercial Drug Procurement include Viseven, Bionical Emas, Almac, BMclinical, Myonex, McKesson, Parexel, Patheon and Clinigen, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Commercial Drug Procurement, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Commercial Drug Procurement, also provides the revenue of main regions and countries. Of the upcoming market potential for Commercial Drug Procurement, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Commercial Drug Procurement revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Commercial Drug Procurement market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Commercial Drug Procurement revenue, projected growth trends, production technology, application and end-user industry.

Commercial Drug Procurement Segment by Company

Viseven

Bionical Emas

Almac

BMclinical

Myonex

McKesson

Parexel

Patheon

Clinigen

UPS Healthcare

Catalent

Endpoint Clinical

Signant Health

YPrime

Commercial Drug Procurement Segment by Type

Tender

Direct Procurement

Competitive Negotiation

Others

Commercial Drug Procurement Segment by Application

Life Sciences

Clinical Trials

Others

Commercial Drug Procurement Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Commercial Drug Procurement market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Commercial Drug Procurement and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Commercial Drug Procurement.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Commercial Drug Procurement in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Commercial Drug Procurement company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Commercial Drug Procurement revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Commercial Drug Procurement Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Tender Major Player Table 3. Direct Procurement Major Player Table 4. Competitive Negotiation Major Player Table 5. Others Major Player Table 6. Global Commercial Drug Procurement Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Life Sciences Major Player Table 8. Clinical Trials Major Player Table 9. Others Major Player Table 10. Commercial Drug Procurement Industry Trends Table 11. Commercial Drug Procurement Industry Drivers Table 12. Commercial Drug Procurement Industry Opportunities and Challenges Table 13. Commercial Drug Procurement Industry Restraints Table 14. Global Commercial Drug Procurement Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Commercial Drug Procurement Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Commercial Drug Procurement Market Share by Region (2021-2026) Table 17. Global Commercial Drug Procurement Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Commercial Drug Procurement Market Share by Region (2027-2032) Table 19. Global Commercial Drug Procurement Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Commercial Drug Procurement Revenue Market Share by Players (2021-2026) Table 21. Global Commercial Drug Procurement Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Commercial Drug Procurement Key Players Headquarters & Area Served Table 23. Global Commercial Drug Procurement Players, Product Type & Application Table 24. Global Commercial Drug Procurement Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Commercial Drug Procurement by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Commercial Drug Procurement Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Commercial Drug Procurement Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Commercial Drug Procurement Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Commercial Drug Procurement Revenue Market Share by Type (2021-2026) Table 31. Global Commercial Drug Procurement Revenue Market Share by Type (2027-2032) Table 32. Global Commercial Drug Procurement Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Commercial Drug Procurement Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Commercial Drug Procurement Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Commercial Drug Procurement Revenue Market Share by Application (2021-2026) Table 36. Global Commercial Drug Procurement Revenue Market Share by Application (2027-2032) Table 37. Viseven Company Information Table 38. Viseven Business Overview Table 39. Viseven Commercial Drug Procurement Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Viseven Commercial Drug Procurement Product Portfolio Table 41. Viseven Recent Development Table 42. Bionical Emas Company Information Table 43. Bionical Emas Business Overview Table 44. Bionical Emas Commercial Drug Procurement Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Bionical Emas Commercial Drug Procurement Product Portfolio Table 46. Bionical Emas Recent Development Table 47. Almac Company Information Table 48. Almac Business Overview Table 49. Almac Commercial Drug Procurement Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Almac Commercial Drug Procurement Product Portfolio Table 51. Almac Recent Development Table 52. BMclinical Company Information Table 53. BMclinical Business Overview Table 54. BMclinical Commercial Drug Procurement Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. BMclinical Commercial Drug Procurement Product Portfolio Table 56. BMclinical Recent Development Table 57. Myonex Company Information Table 58. Myonex Business Overview Table 59. Myonex Commercial Drug Procurement Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Myonex Commercial Drug Procurement Product Portfolio Table 61. Myonex Recent Development Table 62. McKesson Company Information Table 63. McKesson Business Overview Table 64. McKesson Commercial Drug Procurement Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. McKesson Commercial Drug Procurement Product Portfolio Table 66. McKesson Recent Development Table 67. Parexel Company Information Table 68. Parexel Business Overview Table 69. Parexel Commercial Drug Procurement Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Parexel Commercial Drug Procurement Product Portfolio Table 71. Parexel Recent Development Table 72. Patheon Company Information Table 73. Patheon Business Overview Table 74. Patheon Commercial Drug Procurement Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Patheon Commercial Drug Procurement Product Portfolio Table 76. Patheon Recent Development Table 77. Clinigen Company Information Table 78. Clinigen Business Overview Table 79. Clinigen Commercial Drug Procurement Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Clinigen Commercial Drug Procurement Product Portfolio Table 81. Clinigen Recent Development Table 82. UPS Healthcare Company Information Table 83. UPS Healthcare Business Overview Table 84. UPS Healthcare Commercial Drug Procurement Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. UPS Healthcare Commercial Drug Procurement Product Portfolio Table 86. UPS Healthcare Recent Development Table 87. Catalent Company Information Table 88. Catalent Business Overview Table 89. Catalent Commercial Drug Procurement Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. Catalent Commercial Drug Procurement Product Portfolio Table 91. Catalent Recent Development Table 92. Endpoint Clinical Company Information Table 93. Endpoint Clinical Business Overview Table 94. Endpoint Clinical Commercial Drug Procurement Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Endpoint Clinical Commercial Drug Procurement Product Portfolio Table 96. Endpoint Clinical Recent Development Table 97. Signant Health Company Information Table 98. Signant Health Business Overview Table 99. Signant Health Commercial Drug Procurement Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Signant Health Commercial Drug Procurement Product Portfolio Table 101. Signant Health Recent Development Table 102. YPrime Company Information Table 103. YPrime Business Overview Table 104. YPrime Commercial Drug Procurement Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. YPrime Commercial Drug Procurement Product Portfolio Table 106. YPrime Recent Development Table 107. North America Commercial Drug Procurement Revenue by Type (2021-2026) & (US$ Million) Table 108. North America Commercial Drug Procurement Revenue by Type (2027-2032) & (US$ Million) Table 109. North America Commercial Drug Procurement Revenue by Application (2021-2026) & (US$ Million) Table 110. North America Commercial Drug Procurement Revenue by Application (2027-2032) & (US$ Million) Table 111. North America Commercial Drug Procurement Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 112. North America Commercial Drug Procurement Revenue by Country (2021-2026) & (US$ Million) Table 113. North America Commercial Drug Procurement Revenue by Country (US$ Million) & (2027-2032) Table 114. Europe Commercial Drug Procurement Revenue by Type (2021-2026) & (US$ Million) Table 115. Europe Commercial Drug Procurement Revenue by Type (2027-2032) & (US$ Million) Table 116. Europe Commercial Drug Procurement Revenue by Application (2021-2026) & (US$ Million) Table 117. Europe Commercial Drug Procurement Revenue by Application (2027-2032) & (US$ Million) Table 118. Europe Commercial Drug Procurement Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 119. Europe Commercial Drug Procurement Revenue by Country (2021-2026) & (US$ Million) Table 120. Europe Commercial Drug Procurement Revenue by Country (US$ Million) & (2027-2032) Table 121. China Commercial Drug Procurement Revenue by Type (2021-2026) & (US$ Million) Table 122. China Commercial Drug Procurement Revenue by Type (2027-2032) & (US$ Million) Table 123. China Commercial Drug Procurement Revenue by Application (2021-2026) & (US$ Million) Table 124. China Commercial Drug Procurement Revenue by Application (2027-2032) & (US$ Million) Table 125. Asia Commercial Drug Procurement Revenue by Type (2021-2026) & (US$ Million) Table 126. Asia Commercial Drug Procurement Revenue by Type (2027-2032) & (US$ Million) Table 127. Asia Commercial Drug Procurement Revenue by Application (2021-2026) & (US$ Million) Table 128. Asia Commercial Drug Procurement Revenue by Application (2027-2032) & (US$ Million) Table 129. Asia Commercial Drug Procurement Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 130. Asia Commercial Drug Procurement Revenue by Region (US$ Million) & (2021-2026) Table 131. Asia Commercial Drug Procurement Revenue by Region (US$ Million) & (2027-2032) Table 132. SAMEA Commercial Drug Procurement Revenue by Type (2021-2026) & (US$ Million) Table 133. SAMEA Commercial Drug Procurement Revenue by Type (2027-2032) & (US$ Million) Table 134. SAMEA Commercial Drug Procurement Revenue by Application (2021-2026) & (US$ Million) Table 135. SAMEA Commercial Drug Procurement Revenue by Application (2027-2032) & (US$ Million) Table 136. SAMEA Commercial Drug Procurement Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 137. SAMEA Commercial Drug Procurement Revenue by Country (2021-2026) & (US$ Million) Table 138. SAMEA Commercial Drug Procurement Revenue by Country (US$ Million) & (2027-2032) Table 139. Research Programs/Design for This Report Table 140. Authors List of This Report Table 141. Secondary Sources Table 142. Primary Sources List of Figures Figure 1. Commercial Drug Procurement Image Figure 2. Global Commercial Drug Procurement Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Commercial Drug Procurement Market Size Share 2021 VS 2025 VS 2032 Figure 4. Tender Image Figure 5. Direct Procurement Image Figure 6. Competitive Negotiation Image Figure 7. Others Image Figure 8. Global Commercial Drug Procurement Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Commercial Drug Procurement Market Size Share 2021 VS 2025 VS 2032 Figure 10. Life Sciences Image Figure 11. Clinical Trials Image Figure 12. Others Image Figure 13. Global Commercial Drug Procurement Market Size (US$ Million) & (2021-2032) Figure 14. Global Commercial Drug Procurement Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Commercial Drug Procurement Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Commercial Drug Procurement Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Commercial Drug Procurement Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Commercial Drug Procurement Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Commercial Drug Procurement Revenue Market Share by Type (2021-2032) Figure 21. Global Commercial Drug Procurement Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Commercial Drug Procurement Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Commercial Drug Procurement Revenue Market Share by Application (2021-2032) Figure 24. North America Commercial Drug Procurement Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Commercial Drug Procurement Revenue Share by Type (2021-2032) Figure 26. North America Commercial Drug Procurement Revenue Share by Application (2021-2032) Figure 27. North America Commercial Drug Procurement Revenue Share by Country (2021-2032) Figure 28. United States Commercial Drug Procurement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Commercial Drug Procurement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Commercial Drug Procurement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Commercial Drug Procurement Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Commercial Drug Procurement Revenue Share by Type (2021-2032) Figure 33. Europe Commercial Drug Procurement Revenue Share by Application (2021-2032) Figure 34. Europe Commercial Drug Procurement Revenue Share by Country (2021-2032) Figure 35. Germany Commercial Drug Procurement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Commercial Drug Procurement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Commercial Drug Procurement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Commercial Drug Procurement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Commercial Drug Procurement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Commercial Drug Procurement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Commercial Drug Procurement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Commercial Drug Procurement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Commercial Drug Procurement Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Commercial Drug Procurement Revenue Share by Type (2021-2032) Figure 45. China Commercial Drug Procurement Revenue Share by Application (2021-2032) Figure 46. Asia Commercial Drug Procurement Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Commercial Drug Procurement Revenue Share by Type (2021-2032) Figure 48. Asia Commercial Drug Procurement Revenue Share by Application (2021-2032) Figure 49. Asia Commercial Drug Procurement Revenue Share by Region (2021-2032) Figure 50. Japan Commercial Drug Procurement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Commercial Drug Procurement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Commercial Drug Procurement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Commercial Drug Procurement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Commercial Drug Procurement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Commercial Drug Procurement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Commercial Drug Procurement Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Commercial Drug Procurement Revenue Share by Type (2021-2032) Figure 58. SAMEA Commercial Drug Procurement Revenue Share by Application (2021-2032) Figure 59. SAMEA Commercial Drug Procurement Revenue Share by Country (2021-2032) Figure 60. Brazil Commercial Drug Procurement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Commercial Drug Procurement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Commercial Drug Procurement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Commercial Drug Procurement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Commercial Drug Procurement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Commercial Drug Procurement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Commercial Drug Procurement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Commercial Drug Procurement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Commercial Drug Procurement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Commercial Drug Procurement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Commercial Drug Procurement Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Tender
  • Direct Procurement
  • Competitive Negotiation
  • Others
Applications
  • Life Sciences
  • Clinical Trials
  • Others
Companies covered
  • Viseven
  • Bionical Emas
  • Almac
  • BMclinical
  • Myonex
  • McKesson
  • Parexel
  • Patheon
  • Clinigen
  • UPS Healthcare
  • Catalent
  • Endpoint Clinical
  • Signant Health
  • YPrime

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Commercial Drug Procurement Market by Type
  3. 1.2.1 Global Commercial Drug Procurement Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Tender
  5. 1.2.3 Direct Procurement
  6. 1.2.4 Competitive Negotiation
  7. 1.2.5 Others
  8. 1.3 Commercial Drug Procurement Market by Application
  9. 1.3.1 Global Commercial Drug Procurement Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Life Sciences
  11. 1.3.3 Clinical Trials
  12. 1.3.4 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Commercial Drug Procurement Market Dynamics
  1. 2.1 Commercial Drug Procurement Industry Trends
  2. 2.2 Commercial Drug Procurement Industry Drivers
  3. 2.3 Commercial Drug Procurement Industry Opportunities and Challenges
  4. 2.4 Commercial Drug Procurement Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Commercial Drug Procurement Market Perspective (2021-2032)
  2. 3.2 Global Commercial Drug Procurement Growth Trends by Region
  3. 3.2.1 Global Commercial Drug Procurement Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Commercial Drug Procurement Market Size by Region (2021-2026)
  5. 3.2.3 Global Commercial Drug Procurement Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Commercial Drug Procurement Revenue by Players
  2. 4.1.1 Global Commercial Drug Procurement Revenue by Players (2021-2026)
  3. 4.1.2 Global Commercial Drug Procurement Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Commercial Drug Procurement Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Commercial Drug Procurement Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Commercial Drug Procurement Key Players Headquarters & Area Served
  7. 4.4 Global Commercial Drug Procurement Players, Product Type & Application
  8. 4.5 Global Commercial Drug Procurement Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Commercial Drug Procurement Market CR5 and HHI
  11. 4.6.3 2025 Commercial Drug Procurement Tier 1, Tier 2, and Tier 3
5 Commercial Drug Procurement Market Size by Type
  1. 5.1 Global Commercial Drug Procurement Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Commercial Drug Procurement Revenue by Type (2021-2032)
  3. 5.3 Global Commercial Drug Procurement Revenue Market Share by Type (2021-2032)
6 Commercial Drug Procurement Market Size by Application
  1. 6.1 Global Commercial Drug Procurement Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Commercial Drug Procurement Revenue by Application (2021-2032)
  3. 6.3 Global Commercial Drug Procurement Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Viseven
  2. 7.1.1 Viseven Company Information
  3. 7.1.2 Viseven Business Overview
  4. 7.1.3 Viseven Commercial Drug Procurement Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Viseven Commercial Drug Procurement Product Portfolio
  6. 7.1.5 Viseven Recent Developments
  7. 7.2 Bionical Emas
  8. 7.2.1 Bionical Emas Company Information
  9. 7.2.2 Bionical Emas Business Overview
  10. 7.2.3 Bionical Emas Commercial Drug Procurement Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Bionical Emas Commercial Drug Procurement Product Portfolio
  12. 7.2.5 Bionical Emas Recent Developments
  13. 7.3 Almac
  14. 7.3.1 Almac Company Information
  15. 7.3.2 Almac Business Overview
  16. 7.3.3 Almac Commercial Drug Procurement Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Almac Commercial Drug Procurement Product Portfolio
  18. 7.3.5 Almac Recent Developments
  19. 7.4 BMclinical
  20. 7.4.1 BMclinical Company Information
  21. 7.4.2 BMclinical Business Overview
  22. 7.4.3 BMclinical Commercial Drug Procurement Revenue and Gross Margin (2021-2026)
  23. 7.4.4 BMclinical Commercial Drug Procurement Product Portfolio
  24. 7.4.5 BMclinical Recent Developments
  25. 7.5 Myonex
  26. 7.5.1 Myonex Company Information
  27. 7.5.2 Myonex Business Overview
  28. 7.5.3 Myonex Commercial Drug Procurement Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Myonex Commercial Drug Procurement Product Portfolio
  30. 7.5.5 Myonex Recent Developments
  31. 7.6 McKesson
  32. 7.6.1 McKesson Company Information
  33. 7.6.2 McKesson Business Overview
  34. 7.6.3 McKesson Commercial Drug Procurement Revenue and Gross Margin (2021-2026)
  35. 7.6.4 McKesson Commercial Drug Procurement Product Portfolio
  36. 7.6.5 McKesson Recent Developments
  37. 7.7 Parexel
  38. 7.7.1 Parexel Company Information
  39. 7.7.2 Parexel Business Overview
  40. 7.7.3 Parexel Commercial Drug Procurement Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Parexel Commercial Drug Procurement Product Portfolio
  42. 7.7.5 Parexel Recent Developments
  43. 7.8 Patheon
  44. 7.8.1 Patheon Company Information
  45. 7.8.2 Patheon Business Overview
  46. 7.8.3 Patheon Commercial Drug Procurement Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Patheon Commercial Drug Procurement Product Portfolio
  48. 7.8.5 Patheon Recent Developments
  49. 7.9 Clinigen
  50. 7.9.1 Clinigen Company Information
  51. 7.9.2 Clinigen Business Overview
  52. 7.9.3 Clinigen Commercial Drug Procurement Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Clinigen Commercial Drug Procurement Product Portfolio
  54. 7.9.5 Clinigen Recent Developments
  55. 7.10 UPS Healthcare
  56. 7.10.1 UPS Healthcare Company Information
  57. 7.10.2 UPS Healthcare Business Overview
  58. 7.10.3 UPS Healthcare Commercial Drug Procurement Revenue and Gross Margin (2021-2026)
  59. 7.10.4 UPS Healthcare Commercial Drug Procurement Product Portfolio
  60. 7.10.5 UPS Healthcare Recent Developments
  61. 7.11 Catalent
  62. 7.11.1 Catalent Company Information
  63. 7.11.2 Catalent Business Overview
  64. 7.11.3 Catalent Commercial Drug Procurement Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Catalent Commercial Drug Procurement Product Portfolio
  66. 7.11.5 Catalent Recent Developments
  67. 7.12 Endpoint Clinical
  68. 7.12.1 Endpoint Clinical Company Information
  69. 7.12.2 Endpoint Clinical Business Overview
  70. 7.12.3 Endpoint Clinical Commercial Drug Procurement Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Endpoint Clinical Commercial Drug Procurement Product Portfolio
  72. 7.12.5 Endpoint Clinical Recent Developments
  73. 7.13 Signant Health
  74. 7.13.1 Signant Health Company Information
  75. 7.13.2 Signant Health Business Overview
  76. 7.13.3 Signant Health Commercial Drug Procurement Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Signant Health Commercial Drug Procurement Product Portfolio
  78. 7.13.5 Signant Health Recent Developments
  79. 7.14 YPrime
  80. 7.14.1 YPrime Company Information
  81. 7.14.2 YPrime Business Overview
  82. 7.14.3 YPrime Commercial Drug Procurement Revenue and Gross Margin (2021-2026)
  83. 7.14.4 YPrime Commercial Drug Procurement Product Portfolio
  84. 7.14.5 YPrime Recent Developments
8 North America
  1. 8.1 North America Commercial Drug Procurement Revenue (2021-2032)
  2. 8.2 North America Commercial Drug Procurement Revenue by Type (2021-2032)
  3. 8.2.1 North America Commercial Drug Procurement Revenue by Type (2021-2026)
  4. 8.2.2 North America Commercial Drug Procurement Revenue by Type (2027-2032)
  5. 8.3 North America Commercial Drug Procurement Revenue Share by Type (2021-2032)
  6. 8.4 North America Commercial Drug Procurement Revenue by Application (2021-2032)
  7. 8.4.1 North America Commercial Drug Procurement Revenue by Application (2021-2026)
  8. 8.4.2 North America Commercial Drug Procurement Revenue by Application (2027-2032)
  9. 8.5 North America Commercial Drug Procurement Revenue Share by Application (2021-2032)
  10. 8.6 North America Commercial Drug Procurement Revenue by Country
  11. 8.6.1 North America Commercial Drug Procurement Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Commercial Drug Procurement Revenue by Country (2021-2026)
  13. 8.6.3 North America Commercial Drug Procurement Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Commercial Drug Procurement Revenue (2021-2032)
  2. 9.2 Europe Commercial Drug Procurement Revenue by Type (2021-2032)
  3. 9.2.1 Europe Commercial Drug Procurement Revenue by Type (2021-2026)
  4. 9.2.2 Europe Commercial Drug Procurement Revenue by Type (2027-2032)
  5. 9.3 Europe Commercial Drug Procurement Revenue Share by Type (2021-2032)
  6. 9.4 Europe Commercial Drug Procurement Revenue by Application (2021-2032)
  7. 9.4.1 Europe Commercial Drug Procurement Revenue by Application (2021-2026)
  8. 9.4.2 Europe Commercial Drug Procurement Revenue by Application (2027-2032)
  9. 9.5 Europe Commercial Drug Procurement Revenue Share by Application (2021-2032)
  10. 9.6 Europe Commercial Drug Procurement Revenue by Country
  11. 9.6.1 Europe Commercial Drug Procurement Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Commercial Drug Procurement Revenue by Country (2021-2026)
  13. 9.6.3 Europe Commercial Drug Procurement Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Commercial Drug Procurement Revenue (2021-2032)
  2. 10.2 China Commercial Drug Procurement Revenue by Type (2021-2032)
  3. 10.2.1 China Commercial Drug Procurement Revenue by Type (2021-2026)
  4. 10.2.2 China Commercial Drug Procurement Revenue by Type (2027-2032)
  5. 10.3 China Commercial Drug Procurement Revenue Share by Type (2021-2032)
  6. 10.4 China Commercial Drug Procurement Revenue by Application (2021-2032)
  7. 10.4.1 China Commercial Drug Procurement Revenue by Application (2021-2026)
  8. 10.4.2 China Commercial Drug Procurement Revenue by Application (2027-2032)
  9. 10.5 China Commercial Drug Procurement Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Commercial Drug Procurement Revenue (2021-2032)
  2. 11.2 Asia Commercial Drug Procurement Revenue by Type (2021-2032)
  3. 11.2.1 Asia Commercial Drug Procurement Revenue by Type (2021-2026)
  4. 11.2.2 Asia Commercial Drug Procurement Revenue by Type (2027-2032)
  5. 11.3 Asia Commercial Drug Procurement Revenue Share by Type (2021-2032)
  6. 11.4 Asia Commercial Drug Procurement Revenue by Application (2021-2032)
  7. 11.4.1 Asia Commercial Drug Procurement Revenue by Application (2021-2026)
  8. 11.4.2 Asia Commercial Drug Procurement Revenue by Application (2027-2032)
  9. 11.5 Asia Commercial Drug Procurement Revenue Share by Application (2021-2032)
  10. 11.6 Asia Commercial Drug Procurement Revenue by Country
  11. 11.6.1 Asia Commercial Drug Procurement Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Commercial Drug Procurement Revenue by Country (2021-2026)
  13. 11.6.3 Asia Commercial Drug Procurement Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Commercial Drug Procurement Revenue (2021-2032)
  2. 12.2 SAMEA Commercial Drug Procurement Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Commercial Drug Procurement Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Commercial Drug Procurement Revenue by Type (2027-2032)
  5. 12.3 SAMEA Commercial Drug Procurement Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Commercial Drug Procurement Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Commercial Drug Procurement Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Commercial Drug Procurement Revenue by Application (2027-2032)
  9. 12.5 SAMEA Commercial Drug Procurement Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Commercial Drug Procurement Revenue by Country
  11. 12.6.1 SAMEA Commercial Drug Procurement Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Commercial Drug Procurement Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Commercial Drug Procurement Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst